Seeking Clues to Astrazeneca (AZN) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Astrazeneca (AZN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the ...
SA Asks: What's the most attractive weight-loss stock right now?
What's the most attractive weight-loss stock right now? We asked Seeking Alpha analysts Edmund Ingham, Stephen Ayers and Oneil Trader for their picks. Read more here.
The Armenian Reporter1h
HHM Wealth Advisors LLC Has $76,000 Holdings in AstraZeneca PLC (NASDAQ:AZN)
HHM Wealth Advisors LLC grew its stake in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 38.8% during the 4th ...
Amgen's SWOT analysis: stock outlook amid obesity drug race
Amgen Inc (NASDAQ:AMGN)., a leading biopharmaceutical company with a market capitalization of $155 billion, is at a pivotal juncture as it navigates the competitive landscape of innovative ...
24/7 Wall St. on MSN14h
The Dow Jones Industrials Are Winning 2025: 4 Highest-Yielding Dogs of the Dow Are Steals
With the overall stock market very overbought, the four highest-yielding Dogs of the Dow look like outstanding ideas now.
JD Supra13h
China Unveils New Anti-Monopoly Guidelines for the Pharmaceutical Sector
China's State Council issued new Anti-Monopoly Guidelines for the Pharmaceutical Sector (the "Guidelines") effective January 24, 2025. The ...
Onco-Innovations Limited: Onco-Innovations Completes Acquisition of Inka Health to Accelerate AI-Driven Cancer Research and Drug Development
VANCOUVER, BC / ACCESS Newswire / February 3, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce, further to its news release dated ...
Weatherford Democrat10h
Onco-Innovations Completes Acquisition of Inka Health to Accelerate AI-Driven Cancer Research and Drug Development
VANCOUVER, BC / ACCESS Newswire / February 3, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce, further to its news release dated ...
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca
If you purchased or acquired securities in AstraZeneca between between February 23, 2022 and December 17, 2024 and would like ...
J.P. Morgan Keeps Their Buy Rating on AstraZeneca (AZN)
In a report released today, James Gordon from J.P. Morgan maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target ...
AstraZeneca Blames 'Toxic' Climate As It Walks Away from Over $550 Million UK Vaccine Plant
AstraZeneca scrapped plans for a £450 million UK vaccine plant after rejecting a £78 million government offer, citing ...
UK hits back at AstraZeneca over collapse of investment deal
Britain on Monday hit back at AstraZeneca over the collapse of a 450 million pound ($558.5 million) investment, saying the drugmaker had scaled back the research and development portion of its plans, ...